These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 17666367

  • 1. Characteristics and outcome of respiratory syncytial virus infection in patients with leukemia.
    Torres HA, Aguilera EA, Mattiuzzi GN, Cabanillas ME, Rohatgi N, Sepulveda CA, Kantarjian HM, Jiang Y, Safdar A, Raad II, Chemaly RF.
    Haematologica; 2007 Sep; 92(9):1216-23. PubMed ID: 17666367
    [Abstract] [Full Text] [Related]

  • 2. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.
    Whimbey E, Champlin RE, Englund JA, Mirza NQ, Piedra PA, Goodrich JM, Przepiorka D, Luna MA, Morice RC, Neumann JL.
    Bone Marrow Transplant; 1995 Sep; 16(3):393-9. PubMed ID: 8535312
    [Abstract] [Full Text] [Related]

  • 3. Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.
    Shah DP, Ghantoji SS, Shah JN, El Taoum KK, Jiang Y, Popat U, Hosing C, Rondon G, Tarrand JJ, Champlin RE, Chemaly RF.
    J Antimicrob Chemother; 2013 Aug; 68(8):1872-80. PubMed ID: 23572228
    [Abstract] [Full Text] [Related]

  • 4. Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database.
    Law BJ, Wang EE, MacDonald N, McDonald J, Dobson S, Boucher F, Langley J, Robinson J, Mitchell I, Stephens D.
    Pediatrics; 1997 Mar; 99(3):E7. PubMed ID: 9099772
    [Abstract] [Full Text] [Related]

  • 5. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
    Avetisyan G, Mattsson J, Sparrelid E, Ljungman P.
    Transplantation; 2009 Nov 27; 88(10):1222-6. PubMed ID: 19935377
    [Abstract] [Full Text] [Related]

  • 6. Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients.
    Foolad F, Aitken SL, Shigle TL, Prayag A, Ghantoji S, Ariza-Heredia E, Chemaly RF.
    Clin Infect Dis; 2019 May 02; 68(10):1641-1649. PubMed ID: 30202920
    [Abstract] [Full Text] [Related]

  • 7. The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management.
    Anaissie EJ, Mahfouz TH, Aslan T, Pouli A, Desikan R, Fassas A, Barlogie B.
    Blood; 2004 Mar 01; 103(5):1611-7. PubMed ID: 14525792
    [Abstract] [Full Text] [Related]

  • 8. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience.
    DeVincenzo JP, Hirsch RL, Fuentes RJ, Top FH.
    Bone Marrow Transplant; 2000 Jan 01; 25(2):161-5. PubMed ID: 10673674
    [Abstract] [Full Text] [Related]

  • 9. Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection.
    Azzi JM, Kyvernitakis A, Shah DP, El Haddad L, Mahajan SN, Ghantoji SS, Heredia-Ariza E, Chemaly RF.
    J Antimicrob Chemother; 2018 Nov 01; 73(11):3162-3169. PubMed ID: 30113677
    [Abstract] [Full Text] [Related]

  • 10. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
    Gueller S, Duenzinger U, Wolf T, Ajib S, Mousset S, Berger A, Martin H, Serve H, Bug G.
    Transpl Infect Dis; 2013 Aug 01; 15(4):435-40. PubMed ID: 23692664
    [Abstract] [Full Text] [Related]

  • 11. Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients.
    Marcelin JR, Wilson JW, Razonable RR, Mayo Clinic Hematology/Oncology and Transplant Infectious Diseases Services.
    Transpl Infect Dis; 2014 Apr 01; 16(2):242-50. PubMed ID: 24621016
    [Abstract] [Full Text] [Related]

  • 12. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S, Mejías A, Merryman RA, Ahmad N, Jafri HS, Ramilo O.
    Pediatr Infect Dis J; 2007 Dec 01; 26(12):1089-93. PubMed ID: 18043443
    [Abstract] [Full Text] [Related]

  • 13. Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients.
    Damlaj M, Bartoo G, Cartin-Ceba R, Gijima D, Alkhateeb HB, Merten J, Hashmi S, Litzow M, Gastineau D, Hogan W, Patnaik MM.
    Transpl Infect Dis; 2016 Apr 01; 18(2):216-26. PubMed ID: 26909896
    [Abstract] [Full Text] [Related]

  • 14. Comparative effectiveness of aerosolized versus oral ribavirin for the treatment of respiratory syncytial virus infections: A single-center retrospective cohort study and review of the literature.
    Trang TP, Whalen M, Hilts-Horeczko A, Doernberg SB, Liu C.
    Transpl Infect Dis; 2018 Apr 01; 20(2):e12844. PubMed ID: 29360277
    [Abstract] [Full Text] [Related]

  • 15. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
    Glanville AR, Scott AI, Morton JM, Aboyoun CL, Plit ML, Carter IW, Malouf MA.
    J Heart Lung Transplant; 2005 Dec 01; 24(12):2114-9. PubMed ID: 16364859
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection.
    Pelaez A, Lyon GM, Force SD, Ramirez AM, Neujahr DC, Foster M, Naik PM, Gal AA, Mitchell PO, Lawrence EC.
    J Heart Lung Transplant; 2009 Jan 01; 28(1):67-71. PubMed ID: 19134533
    [Abstract] [Full Text] [Related]

  • 17. Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation.
    Li L, Avery R, Budev M, Mossad S, Danziger-Isakov L.
    J Heart Lung Transplant; 2012 Aug 01; 31(8):839-44. PubMed ID: 22621746
    [Abstract] [Full Text] [Related]

  • 18. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.
    Wendt CH, Hertz MI.
    Semin Respir Infect; 1995 Dec 01; 10(4):224-31. PubMed ID: 8668850
    [Abstract] [Full Text] [Related]

  • 19. Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement.
    Seo S, Campbell AP, Xie H, Chien JW, Leisenring WM, Englund JA, Boeckh M.
    Biol Blood Marrow Transplant; 2013 Apr 01; 19(4):589-96. PubMed ID: 23298855
    [Abstract] [Full Text] [Related]

  • 20. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia.
    Whimbey E, Couch RB, Englund JA, Andreeff M, Goodrich JM, Raad II, Lewis V, Mirza N, Luna MA, Baxter B.
    Clin Infect Dis; 1995 Aug 01; 21(2):376-9. PubMed ID: 8562747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.